TECENTRIQ 1200 mg/20mL
atezolizumab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
TECENTRIQ is a injection, solution containing atezolizumab at 1200 mg/20mL, taken intravenous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- TECENTRIQ
- Generic Name
- atezolizumab
- NDC Code (Product)
50242-917- Manufacturer
- Genentech, Inc.
- Strength
- 1200 mg/20mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761034
- Drug Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 05/18/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is TECENTRIQ used for?
TECENTRIQ contains atezolizumab. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is TECENTRIQ a controlled substance?
TECENTRIQ is not classified as a controlled substance by the DEA.
What is the generic name for TECENTRIQ?
The generic name for TECENTRIQ is atezolizumab. There are 1 other brand versions of atezolizumab.
What is the NDC code for TECENTRIQ 1200 mg/20mL?
The NDC (National Drug Code) for TECENTRIQ 1200 mg/20mL is 50242-917, listed by Genentech, Inc..